1. Home
  2. GAME vs BCTX Comparison

GAME vs BCTX Comparison

Compare GAME & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameSquare Holdings Inc.

GAME

GameSquare Holdings Inc.

HOLD

Current Price

$3.06

Market Cap

43.4M

Sector

N/A

ML Signal

HOLD

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.01

Market Cap

36.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAME
BCTX
Founded
2011
2014
Country
United States
Canada
Employees
N/A
4
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
36.6M
IPO Year
2024
2025

Fundamental Metrics

Financial Performance
Metric
GAME
BCTX
Price
$3.06
$4.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
174.3K
186.3K
Earning Date
04-08-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
65.14
N/A
EPS
N/A
N/A
Revenue
$44,999,302.00
N/A
Revenue This Year
$87.12
N/A
Revenue Next Year
$21.14
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$2.60
52 Week High
$3.85
$14.68

Technical Indicators

Market Signals
Indicator
GAME
BCTX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
GAME
BCTX

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: